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Sensitivity to Atypical Mycobacterial Antigens 
in Patients with Crohn's Disease 
Joel Morganroth, BS and David W. Watson, MD 
Twenty-two patients with Crohn's disease were investigated for the presence 
of delayed cutaneous reactions and precipitating antibodies to atypical myco- 
bacterial antigens of Runyon's Groups I, II and III as well as standard PPD. The 
results obtained, when compared to the control groups, do not show an increased 
incidence of sensitivity to such antigens in patients with Crohn's disease. How- 
ever, their potential relevance to the pathogenesis of this disorder remains to be 
determined. 
Since Crolm's original description (l) of 
a granuh)matous disorder involving the ter- 
minal  ileum, distinct from ileocecal tnher- 
culosis, little has been done to elucidate its 
cause. This  is both curious att(l unfortu- 
nate, for its distribution, i)athologic 
features and patterns of recurrence suggest 
numerous possibilities for investigation. 
The  presence of grantdomas has invited 
comparison with disorders exhibi t ing simi- 
lar lesions such as tuberculosis, herylliosis, 
the deep ntycoses and sarcoidosis, but  no 
convincing l)arallels have emerged. 
Speculation has in the main centered 
around either an infectious or an i m m une  
origin. Attempts to isolate an infectious 
agent have been unrewarding but  limited, 
I)eing confined largely to mycol)acterium 
tuberculosis and certain viruses (2). Al- 
though there is little to suggest an immune  
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etiology for this disorder, gra imlomas may 
in some situations constitute morphologic  
evidence of an immune  response. T h e  
granulonlatous reaction to tubercle bacilli 
and many  fungi has long been nnderstood 
as a manifestat ion of delayed hypersensitiv- 
ity; more recently the tissue response in 
schistosomiasis has been shown to have a 
similar basis (3). Still, no organism capable 
of ini t iat ing such an immune  response has 
been found in affected tissues, nor have 
tissues exhibi t ing granulomas been shown 
to contain antigens capable of eliciting an 
immune  response in patients with Crohn 's  
disease (4). 
Although the comparison with sarcoid- 
osis, another  chronic granulomatous  dis- 
order of unknown cause, is somewhat 
strained, the recent finding that  anony- 
mous mycobacteria  could be cultured from 
the tissues of such patients with mycobac- 
teriophage-neutralizing antisera has obvl- 
ous potential  relevance (5, 6). I t  would 
therefore be of interest to know whether  
infection by such organisms was more fre- 
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q u e n t  in i n d i v i d u a l s  wi th  Crohn ' s  disease 
than in the  p o p u l a t i o n  at  large.  I f  t rue,  
such pa t i en t s  m i g h t  be expec t ed  to e x h i b i t  
e i the r  de l ayed  cu t aneous  reac t ions  or  hu-  
m o r a l  a n t i b o d i e s  to these m y c o b a c t e r i a l  
an t igens .  
MATERIALS AND METHODS 
Twenty-two patients with Crohn's disease were 
investigated for the presence of precipitins or 
delayed cutaneous reactions to atypical mycobac- 
terial antigens of Runyon's Groups I, II and III as 
well as PPD. Only patients with typical radiologic 
or histologic features were included. Skin test 
controls were derived from two sources: (1) stu- 
dent nurses at the University of Michigan who 
formed part of a study carried out by the Pulmon- 
ary Disease Section of the Department of Medicine, 
and (2) white navy recruits, aged 17-21 years, 
tested as part of the USPHS-USN cooperative skin 
tes t  program (7). The atypical mycobacterial anti- 
gens were obtained from the National Communica- 
ble Disease Center and contained 0.0001 mg/0.l ml 
(skin test dose). Standard intermediate strength 
PPD was utilized as an additional control. All skin 
tests were carried out on the volar aspect of the 
forearm and were read at 48 hr. At this time the 
diameter of any induration was measured. No 
patients were on corticosteroids or immunosuppres- 
sives. Before the skin tests were applied, blood was 
obtained for double gel diffusion studies by the 
standard microscopic slide technic using the same 
antigens used for skin testing. 
RESULTS 
Control Group 
T h e  U S P H S - U S N  coope ra t ive  skin  test 
p r o g r a m  tes ted  14,261 M i c h i g a n  nava l  re- 
crui ts ,  aged  17-21, w i th  PPD-S a n d  PPD-B 
in a m a n n e r  i den t i ca l  to t ha t  e m p l o y e d  in 
this  s tudy.  I n d u r a t i o n  of 4 m m  or  m o r e  at  
48 h r  in  response  to PPD-S was f o u n d  in 
4 .4% whi le  15.5% m a n i f e s t e d  4 m m  or  
m o r e  of  i n d u r a t i o n  u p o n  b e i n g  tes ted  w i t h  
PPD-B.  T h e  c r i t e r ia  for q u a n t i t a t i n g  the  
d e r m a l  r eac t ions  were  chosen  s imp ly  to 
s epa ra t e  those  w h o  reac t  to the  test f rom 
those w h o  do  not .  N o  o t h e r  i n t e r p r e t a t i o n  
based  u p o n  m a g n i t u d e  of response  was 
a t t e m p t e d .  Mos t  r eac t ions  to PPD-B 
( G r o u p  II )  p r o b a b l y  r ep re sen t  cross reac- 
t ions to st i l l  u n i d e n t i f i e d  myc oba c t e r i a l  in- 
fect ions as do m i n i m a l  (less than  10 mm) 
reac t ions  to PPD-S. The re fo re ,  one  canno t  
use the resul ts  in ou r  two con t ro l  g roups  or 
o u r  p a t i e n t  g r o u p  to der ive  i n f o r m a t i o n  
c o n c e r n i n g  specific in fec t ion  wi th  a given 
m y c o b a c t e r i u m ;  ra the r ,  one shou ld  use a 
gene ra l  i n d e x  of exposu re  to m a n y  myco- 
bac t e r i a l  an t igens  which  is in fact the ob- 
jec t ive  of  this  s tudy.  
I n  the  n u r s i n g  s tudents ,  r eac t ions  of 5 
m m  or  m o r e  of i n d u r a t i o n  were f o u n d  in 
3 . 6 ~  (of 368) tes ted wi th  PPD-S; 20.1~o 
(of 167) tested wi th  PPD-B ( G r o u p  II )  
a n d  51.1~o (of 201) tested wi th  P P D - G  
( G r o u p  I I I ) .  T h e  navy recru i t s  were no t  
tes ted w i th  PPD-G.  T h e s e  resul ts  are sum- 
mar i z e d  in  T a b l e  1. 
Test Group 
E i g h t e e n  pe rcen t  of the  pa t i en t s  wi th  
Crohn ' s  disease (4 of  22) e x h i b i t e d  5 m m  
or  m o r e  of i n d u r a t i o n  to PPD-S. N o n e  of 
the  22 r eac t ed  to PPD-Y ( G r o u p  I) whi le  
13.6% (3 of  22) r e s p o n d e d  wi th  5 m m  or  
m o r e  of i n d u r a t i o n  to b o t h  PPD-B and  
PPD-G.  N o n e  of  the 14 pa t i en t s  whose sera 
were tes ted  h a d  p r e c i p i t a t i n g  a n t i bod i e s  to 
any  of the  four .  an t igens  as m e a s u r e d  by 
d o u b l e  gel  diffusion.  T h e  resul ts  of the 
s tudies  c a r r i e d  ou t  in the p a t i e n t  g r o u p  are 
t a b u l a t e d  in T a b l e  2. 
DISCUSSION 
A l t h o u g h  m i c r o b i o l o g i c  s tudies  in 
C r o h n ' s  disease have  fa i led  to s u p p o r t  an 
infec t ious  e t io logy,  the  ex t en t  of most  in- 
ves t iga t ions  has  been  l imi t ed .  T h e  fact tha t  
o rgan i sms  canno t  be d e m o n s t r a t e d  in  dis- 
eased tissue by  e i the r  d i rec t  s t a in ing  or  
c u l t u r a l  t echn ic  does no t  cons t i tu te  p roof  
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of their absence. A case in point  is 
sarcoidosis. Mycobacteriophages, demon- 
strated in the stools and tissues of patients 
Table 1. Dermal Sensitivity in Control Groups 
Antigen 
Percent of subjects with 
induration > 4 mm 
USPHS-USN study Student nurses 
PPD-S 4.4 (14,261)* 3.6 (368)* 
PPD-B 15.5 (14,261)* 20.1 (167)* 
PPD-G - -  51.1 (201)* 
PPD-S, standard PPD; PPD-B, Group II; and 
PPD-G, Group III. 
* Numbers in parentheses indicate number of 
subjects tested. 
Table 2. Immune Response in Patients 
with Crohn's Disease 
Age 
Patients (yr) Sex Skin test DGD* 
JT 13 M All negative Not tested 
AW 35 F Group II, III All negative 
(0.5 cm) 
FL 50 F PPD (0.5 cm) Not tested 
FB 28 M All negative Not tested 
ET 49 F Group l l ,  l l l  Not tested 
(0.5 cm) 
MK 22 F All negative Not tested 
JB 25 F PPD (0.5 cm) Not tested 
CG 25 F All negative Not tested 
WW 50 F All negative Not tested 
NL 48 F All negative All negative 
WG 20 M All negative All negative 
BS 42 F All negative All negative 
SD 38 M PPD (0.5 cm) All negative 
DS 19 M All negative All negative 
EH 54 F All negative All negative 
KB 50 F All negative Atl negative 
DL 22 M All negative All negative 
JC 26 M All negative All negative 
RW 25 M All negative All negative 
ZG 20 M All negative All negative 
IP 46 F All negative All negative 
CC 54 M PPD, Group All negative 
II, III 
(0.5 cm) 
* DGD, double gel diffusion. 
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with sarcoidosis, are capable of converting 
mycobacteria  to a lysogenous state wherein 
they can be nei ther  seen nor cul tured (8). 
Patients with tuberculosis also harbor  my- 
cobacteriophages, but  in addit ion possess 
phage-neutralizing antibodies. Such anti- 
bodies are not found in patients with sar- 
coidosis. When  tissues from patients with 
sarcoidosis are cuhured  in the presence of 
phage-neutral izing antibodies, atypical my- 
cobacterial strains can frequently be recov- 
ered (5, 6). Furthermore,  the simultaneous 
infection of guinea pigs with tubercle bacil- 
li and mycobacter iophages produces a sar- 
coid-like lesion from which atypical myco- 
bacteria can be recovered (9). These  
findings led Mankiewicz and Beland to 
postulate that sarcoidosis might  result from 
infection with these atypical organisms 
wherein a transient overt  stage was fol- 
lowed by a lysogenous stage; therefore, 
mycobacteria,  even though present, could 
not be demonstrated.  
T h a t  a similar si tuation might  exist in 
patients with Crohn 's  disease is a possibility 
worth considering. Al though sarcoidosis 
and Crohn 's  disease appear  to be entities 
distinct from one another,  certain points of 
similarity do exist. T h e y  are both chronic 
granulomatous  disorders o£ obscure origin, 
and anergy for delayed hypersensitivity has 
been associated with both. While  firmly 
established for sarcoidosis, such anergy con- 
tinues to be debated in the case of Crohn's  
disease. T h e  results of some studies suppor t  
the existence of anergy (4) while others do 
not (10). T h e  best controlled and most 
convincing study, that  of Fletcher and Hin- 
ton (10), suggest that  anergy is not charac- 
teristic of patients with Crohn 's  disease. I t  
should be remembered,  however, that  even 
in sarcoidosis, anergy i~ not complete;  some 
antigens continue to elicit delayed hyper- 
sensitivity reactions in a normal  manner .  
A fur ther  point  of similarity between the 
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two disorders is the recent finding that 
approximately one-half of patients with 
Crohn's disease develop a positive reaction 
to the Kveim antigen (I1).  Previous 
studies of the Kveim reaction in Crohn's 
disease have been negative (4). Mitchell et 
al point out, however, that biopsies were 
not done and smaller amounts of test mate- 
rial were employed in the studies yielding 
negative results. 
In  view o[ these similarities between 
Crohn's disease and sarcoidosis and the 
finding of atypical mycobacterial species in 
the latter, it seemed worthwhile to deter- 
mine whether patients with Croh~fs disease 
demonstrated more frequent cutaneous or 
serologic reactions to atypical mycobacteri- 
al antigens than controls. 
The  results of this study indicate that no 
increase in delayed cutaneous responses is 
present in such patients in comparison 
with control groups. Furthermore, no cir- 
culating antibodies could be demonstrated 
to these antigens by the double gel dig 
fusion technic. 
Alternative interpretations of these re- 
suits are possible. First, tissue involvement 
with atypical mycobacteria may not be 
characteristic of patients with Crohn's dis- 
ease. Dermal reactivity would likely be 
present if such were the case. However, 
mycobacteria other than the ones utilized 
in this study might be responsible. If so, 
o n e  n l n s t  a s s L l n l e  they are n o t  cross-reactive 
with Runyon 's  Groups I, II or I I I  or stand- 
ard PPD. There  is also no certainty that 
such antigens existing in a lysogenous state 
are immunogenic. Second, these results 
would be consistent with a state of anergy 
to the antigens employed. This possibility 
cannot be excluded although the results of 
Fletcher and Hin tmfs  study would appear 
to make this unlikely. The  recent demon- 
stration that patients with Crohn's disease 
are less susceptible to primary sensitization 
with 2,4 dinitrochlorobenzene than normal 
controls (12) may, however, alter this be- 
lief. I t  may be that while established 
delayed hypersensitivity is not interfered 
with, there is an impairment in the ability 
to acquire such sensitivity af'ter the advent 
o1! Crohn's disease. 
Although the results of the present study 
do not supl)ort a role for atypical mycobac- 
terial organisms of Runyon's  Groups I, I I  
or I I I  in the pathogenesis of Crohn's dis- 
ease, the possibility that some obscure my. 
cobacterial species ntay play such a role 
shonld not lie prematurely abandoned. It is 
perhaps noteworthy that azulfidine may 
have a 1)eneficial effect on the course of 
Crohn's disease. This ntedication contains a 
5-amino salicylic acid moiety as well as a 
sulfapyridine molecule similar to the tuber- 
culostatic drug PAS. Sulphones, analognes 
of p-aminobenzoic acid, sulphonamides and 
aminosalicylic acid are effective in myco- 
bacterial disorders such as leprosy (13). 
I t  would be worthwhile to attempt to 
isolate atypical mycobacterial organisms 
from the affected tissues of patients with 
Crohn's disease, utilizing antimycobacterio- 
phages in the culture system. 
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